News
October 07, 2025
STRATA Highlights Excimer Laser as Effective Option for Atopic Dermatitis
HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) is marking Eczema Awareness Month by underscoring the growing body of clinical evidence supporting its XTRAC® Excimer Laser (308 nm) as ...
HORSHAM, PA – As Eczema Awareness Month unfolds, STRATA Skin Sciences, Inc. (NASDAQ: SSKN) is bringing renewed attention to a promising treatment option for atopic dermatitis: the XTRAC® Excimer Laser. The company is highlighting the increasing amount of clinical data that points to the laser’s effectiveness in managing this chronic skin condition.
Atopic dermatitis, commonly known as eczema, affects millions worldwide, causing itchy, inflamed skin. Traditional treatments often involve topical creams and steroids, which can have limitations and potential side effects with long-term use. The XTRAC® Excimer Laser offers a targeted approach, using a specific wavelength of ultraviolet light (308 nm) to treat affected areas.
Unlike full-body light therapy, the XTRAC® laser precisely targets eczema patches, minimizing exposure to healthy skin. This focused approach can lead to faster clearing of lesions and a reduction in itching and inflammation, improving the quality of life for those suffering from eczema.
The growing body of clinical evidence supporting the XTRAC® laser suggests that it can be a valuable tool in the dermatologist's arsenal. The laser works by modulating the immune system within the skin, reducing the inflammatory response that characterizes eczema. This targeted approach can lead to longer periods of remission compared to some other treatments.
STRATA Skin Sciences is committed to raising awareness about eczema and the available treatment options. By highlighting the XTRAC® Excimer Laser during Eczema Awareness Month, the company aims to empower patients to discuss this potential therapy with their dermatologists and explore whether it's a suitable option for managing their condition.
The company emphasizes that the XTRAC® laser is a prescription treatment and should only be administered by qualified healthcare professionals. Patients interested in learning more about the XTRAC® Excimer Laser and its potential benefits for atopic dermatitis are encouraged to consult with their dermatologist to determine if it is the right treatment option for them.
Atopic dermatitis, commonly known as eczema, affects millions worldwide, causing itchy, inflamed skin. Traditional treatments often involve topical creams and steroids, which can have limitations and potential side effects with long-term use. The XTRAC® Excimer Laser offers a targeted approach, using a specific wavelength of ultraviolet light (308 nm) to treat affected areas.
Unlike full-body light therapy, the XTRAC® laser precisely targets eczema patches, minimizing exposure to healthy skin. This focused approach can lead to faster clearing of lesions and a reduction in itching and inflammation, improving the quality of life for those suffering from eczema.
The growing body of clinical evidence supporting the XTRAC® laser suggests that it can be a valuable tool in the dermatologist's arsenal. The laser works by modulating the immune system within the skin, reducing the inflammatory response that characterizes eczema. This targeted approach can lead to longer periods of remission compared to some other treatments.
STRATA Skin Sciences is committed to raising awareness about eczema and the available treatment options. By highlighting the XTRAC® Excimer Laser during Eczema Awareness Month, the company aims to empower patients to discuss this potential therapy with their dermatologists and explore whether it's a suitable option for managing their condition.
The company emphasizes that the XTRAC® laser is a prescription treatment and should only be administered by qualified healthcare professionals. Patients interested in learning more about the XTRAC® Excimer Laser and its potential benefits for atopic dermatitis are encouraged to consult with their dermatologist to determine if it is the right treatment option for them.
Category:
World